Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Prospective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)

A Single Centre Prospective Cohort Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Psoriatic arthritis (PsA) is a complex inflammatory disease with heterogeneous clinical features, which complicates psoriasis in 30% of patients. PsA involves multiple tissues and clinical domains including skins and nails as well as arthritis, spondylitis, enthesitis, and dactylitis. Power Doppler (PD) ultrasonography (PDUS) is a sensitive non-invasive imaging technology used to assess disease activity and treatment response in PsA. This is a prospective, observational, open-label study to investigate disease activity, therapeutic response and bone destruction based on ultrasonography findings in patients with PsA.

Who May Be Eligible (Plain English)

Who May Qualify: - PsA patients as defined by CASPAR criteria - Patients must be able to comply with the visit schedule, treatment plan, laboratory tests and other study procedures - Patients must be given willing to sign a consent form Who Should NOT Join This Trial: - History of other arthritis within the last 12 months - Concomitant disease with acute or chronic infectious diseases - Pregnancy or laction - Poorly tolerated with venipuncture required for blood sampling during the study Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * PsA patients as defined by CASPAR criteria * Patients must be able to comply with the visit schedule, treatment plan, laboratory tests and other study procedures * Patients must be given informed consent Exclusion Criteria: * History of other arthritis within the last 12 months * Concomitant disease with acute or chronic infectious diseases * Pregnancy or laction * Poorly tolerated with venipuncture required for blood sampling during the study

Locations (2)

Department of Rheumatology and Immunology, Jiangsu Province Hospital
Nanjing, Jiangsu, China
Jiangsu Province Hospital
Nanjing, Jiangsu, China